Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Keryx Biopharmaceuticals, Inc.(KERX)

 
123Jump Rating:   Underwriters: Roth Capital Partners
      WestLB Panmure Limited
Status: Priced  
 
Address: FiledDate: 05/19/2000
     
  Filed Price Range ($): $10.00-12.00
       
Telephone: Filed Offer Amount ($ Million): $46.00
       
Fax: Shares Offered (Millions): 5
       
Websites: Shares Outstanding (Millions):
       
Management: IPO Date: 07/27/2000
     
  Final Offer Price ($): $10.00
       
Industry: Biotech Final Offer Size (Millions of Shares): 0.00
       
Employees: Final Offer Amount ($ Million): $0.00
       
Competitors: S-1 Forms:
     
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1997 233.33 1094.4 -861.06 9.77 -881.71 -.11
1998 66.66 2418.27 -2351.61 30.44 -2539.41 -.31
1999 0.00 8735.3 -8735.3 9.97 -9002.76 -1.11
2000 0.00 2495 -2495 0.00 -2467 -.3
* Three Months ended March 31, 2000
 
 
© 1999-2008 123jump.com. All rights reserved